| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Exact Sciences Corp (EXAS) has 15 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. EXAS is classified in the Life Sciences Tools & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| VP | 191.9K | $20.13M | - | |
| VP | 153.7K | $16.13M | - | |
| CFO | 138.7K | $14.55M | - | |
| VP | 137.2K | $14.39M | - | |
| Dir | 34.3K | $3.60M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 22, 2024 | Cunningham Everett54 | Chief Commercial Officer | Sell | 1,350 | $59.78 | $80,703.00 | -3.3% | -10.1% | -17.2% | |
| Feb 22, 2024 | Conroy Kevin T81 | President And CEO | Sell | 11,565 | $59.78 | $691,355.70 | -0.9% | -10.1% | -17.2% | |
| Feb 22, 2024 | Coward D Scott77 | Director | Sell | 663 | $59.78 | $39,634.14 | -1.5% | -10.1% | -17.2% | |
| Feb 22, 2024 | Orville Jacob A76 | General Manager, Screening | Sell | 1,013 | $59.78 | $60,557.14 | -9.5% | -10.1% | -17.2% | |
| Feb 22, 2024 | Herriott James75 | General Counsel | Sell | 291 | $59.78 | $17,395.98 | -3.9% | -10.1% | -17.2% | |
| Feb 22, 2024 | Elliott Jeffrey Thomas79 | Chief Financial Officer | Sell | 1,351 | $59.78 | $80,762.78 | -21.1% | -10.1% | -17.2% | |
| Feb 22, 2024 | Condella Sarah75 | EVP, Human Resources | Sell | 1,013 | $59.78 | $60,557.14 | -1.4% | -10.1% | -17.2% | |
| Feb 22, 2024 | Baranick Brian75 | Gen. Mgr., Precision Oncology | Sell | 1,093 | $59.78 | $65,339.54 | -10.1% | -10.1% | -17.2% | |
| Feb 21, 2024 | Elliott Jeffrey Thomas79 | Chief Financial Officer | Sale+OE | 1,493 | $61.50 | $91,819.50 | -28.7% | -15.4% | -21.8% | |
| Feb 21, 2024 | Orville Jacob A76 | General Manager, Screening | Sale+OE | 1,078 | $61.50 | $66,297.00 | -11.1% | -15.4% | -21.8% |